Specialty Billing
Addiction and Substance Use Treatment Billing
Billing for SUD treatment programs — level-of-care authorization cycles built on ASAM criteria, MAT billing structures, drug-testing compliance, and 42 CFR Part 2 constraints.
Substance use treatment billing combines behavioral health’s program mechanics with its own layers: level-of-care determinations argued through ASAM criteria at admission and every transition, medication-assisted treatment billed across office-based and program models, urine drug testing as both clinical tool and compliance minefield, and confidentiality rules (42 CFR Part 2) that constrain how billing itself may disclose information.
Our addiction treatment billing runs the full apparatus: utilization review coordination with ASAM-framed documentation, authorization continuity across detox-residential-PHP-IOP transitions, MAT claims constructed per program model and payer, UDT billing kept to defensible frequency and panel patterns, and Part 2-aware processes in every disclosure the billing function makes.
Why Addiction & Substance Use Treatment Billing Is Complex
Level-of-care denials are the revenue battleground — payers apply their interpretations of medical-necessity criteria to every admission and continued stay, and winning requires documentation organized around the criteria dimensions payers cite. UDT billing carries enforcement history industry-wide: frequency, panel scope, and definitive-testing patterns must be clinically individualized and documented, because payers analyze testing patterns across providers. Out-of-network prevalence in Texas SUD treatment makes single-case agreements and OON benefit mechanics a standing capability rather than an exception.
Common Service Categories We Bill
- Detoxification and withdrawal management billing
- Residential treatment program claims
- PHP and IOP substance use programs
- Medication-assisted treatment (MAT) services
- Drug testing programs under compliance discipline
Common Denial Causes in Addiction & Substance Use Treatment
- Level-of-care and continued-stay denials
- Authorization lapses at program transitions
- UDT frequency and panel denials
- OON claims stalled without negotiation workflows
Documentation Risks to Watch
- ASAM-dimension documentation thin at admissions and transitions
- UDT orders lacking individualized rationale
- Part 2 consent architecture gaps in billing disclosures
Coding Considerations
- Program billing constructions vary by payer as in behavioral health, with SUD-specific code families layered in
- MAT billing differs by medication and setting — office-based buprenorphine, OTP methadone bundles, and injectable naltrexone each construct differently
Educational note: Coding and payer information on this page is general educational content, not definitive coding, legal, or reimbursement advice. CPT/ICD-10 rules and payer policies change frequently — verify specifics against current official sources and qualified professionals.
Typical Payer Challenges
- Restrictive medical-necessity interpretations at residential levels
- Network adequacy gaps keeping much treatment out-of-network
Addiction & Substance Use Treatment Billing FAQs
Payers keep cutting residential stays short — how do we fight continued-stay denials?
With criteria-organized documentation and disciplined appeals: continued-stay reviews argued dimension by dimension against the criteria the payer claims to apply, peer-to-peer reviews prepared rather than improvised, and expedited appeals used where available. Programs that document to ASAM dimensions from admission win materially more review days than programs that narrate generally.
How do we keep our drug-testing program off payer radar?
By making it defensible rather than invisible: individualized testing frequency tied to clinical phase and risk, panels justified per patient, definitive testing reserved for documented need, and billing patterns you would be comfortable explaining — because payers do pattern analysis across their networks. We audit UDT billing posture as a standing control in SUD engagements.
Related Specialties and Texas Locations
Information on this website is provided for general educational purposes only and does not constitute legal, medical, coding, reimbursement, payer, or compliance advice. Coding and payer requirements change frequently; verify current rules with official sources and qualified professionals before acting.
Talk to us about addiction & substance use treatment billing
Request a free billing assessment and get a clear, no-obligation review of your claims process, denial patterns, and accounts receivable.